{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T13:53:54Z","timestamp":1782482034855,"version":"3.54.5"},"reference-count":38,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2018,10,1]],"date-time":"2018-10-01T00:00:00Z","timestamp":1538352000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Gynecology Obstetrics and Human Reproduction"],"published-print":{"date-parts":[[2018,10]]},"DOI":"10.1016\/j.jogoh.2018.05.015","type":"journal-article","created":{"date-parts":[[2018,6,4]],"date-time":"2018-06-04T21:51:07Z","timestamp":1528149067000},"page":"341-349","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"title":["Can the risks associated with uterine sarcoma morcellation really be prevented? Overview of the role of uterine morcellation in 2018"],"prefix":"10.1016","volume":"47","author":[{"given":"M.","family":"Rousseau","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Morel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Dechoux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.E.","family":"Bouet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Catala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Lefebvre Lacoeuille","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ph","family":"Descamps","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Legendre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"317","key":"10.1016\/j.jogoh.2018.05.015_bib0195","article-title":"Mise \u00e0 jour technique sur le morcellement tissulaire dans le cadre d\u2019une chirurgie gyn\u00e9cologique: Son utilisation, ses complications et les risques li\u00e9s \u00e0 la pr\u00e9sence insoup\u00e7onn\u00e9e de tumeurs malignes","volume":"January","author":"Singh","year":"2015","journal-title":"SOGC"},{"issue":"January (1)","key":"10.1016\/j.jogoh.2018.05.015_bib0200","article-title":"European society of gynecological oncology statement on fibroid and uterine morcellation","volume":"27","author":"Halaska","year":"2017","journal-title":"Int J Gynecol Cancer"},{"key":"10.1016\/j.jogoh.2018.05.015_bib0205","series-title":"Indicateurs de sant\u00e9","author":"Institut canadien d\u2019information sur la sant\u00e9, Statistique Canada","year":"2010"},{"issue":"January (1)","key":"10.1016\/j.jogoh.2018.05.015_bib0210","article-title":"Impact pronostiques de la morcellation chirurgicale en cas de cancers ut\u00e9rins: du \u00abprincipe de pr\u00e9caution\u00bb au \u00abr\u00e9alisme\u00bb","volume":"103","author":"Guyon","year":"2016","journal-title":"Bull Cancer (Paris)"},{"key":"10.1016\/j.jogoh.2018.05.015_bib0215","article-title":"Fibroid surgery puts doctor fighting cancer diagnosis in the spotlight","author":"Levitz","year":"2013","journal-title":"Wall Street J"},{"key":"10.1016\/j.jogoh.2018.05.015_bib0220","article-title":"To morcellate or not: that's the question","author":"Conventus","year":"2015","journal-title":"Conventus"},{"key":"10.1016\/j.jogoh.2018.05.015_bib0225","series-title":"Clinical gynecologic oncology","author":"DiSaia","year":"2012"},{"key":"10.1016\/j.jogoh.2018.05.015_bib0230","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.ijgo.2008.12.009","article-title":"FIGO staging for uterine sarcomas","volume":"104","author":"FIGO committee on gynecologic oncology","year":"2009","journal-title":"Int J Gynecol Obst"},{"key":"10.1016\/j.jogoh.2018.05.015_bib0235","series-title":"Power morcellation on occult malignancy in gynecologic surgery","author":"ACOG","year":"2014"},{"issue":"4","key":"10.1016\/j.jogoh.2018.05.015_bib0240","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/j.jmig.2014.05.010","article-title":"Morcellation during uterine tissue extraction","volume":"21","author":"AAGL","year":"2014","journal-title":"J Minim Invasive Gynecol"},{"key":"10.1016\/j.jogoh.2018.05.015_bib0245","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/s10397-015-0878-4","article-title":"Options on fibroid morcellation: a literature review","volume":"12","author":"Br\u00f6lmann","year":"2015","journal-title":"Gynecol Surg"},{"key":"10.1016\/j.jogoh.2018.05.015_bib0250","article-title":"Value of ultrasonography and magnetic resonance imaging for the characterization of uterine mesenchymal tumors","author":"Bonneau","year":"2013","journal-title":"Acta Obstet Gynecol Scand"},{"key":"10.1016\/j.jogoh.2018.05.015_bib0255","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1016\/j.bpobgyn.2011.07.002","article-title":"Clinical presentation and diagnosis of uterine sarcoma, including imaging","volume":"25","author":"Wu","year":"2011","journal-title":"Best Pract Res Clin Obstet Gynaecol"},{"key":"10.1016\/j.jogoh.2018.05.015_bib0260","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1002\/jcu.20386","article-title":"Can gray-scale and color Doppler sonography differentiate between uterine leiomyosarcoma and leiomyoma?","volume":"35","author":"Exacoustos","year":"2007","journal-title":"J Clin Ultrasound JCU"},{"key":"10.1016\/j.jogoh.2018.05.015_bib0265","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1002\/jmri.21469","article-title":"Carcinosarcoma of the uterus: MR findings","volume":"28","author":"Tanaka","year":"2008","journal-title":"J Magn Reson Imaging JMRI"},{"key":"10.1016\/j.jogoh.2018.05.015_bib0270","unstructured":"Stewart, \u00c9. Differentiating uterine leiomyomas (fibroids) from uterine sarcomas. http:\/\/www.uptodate.com\/contents\/differentiating-uterine-leiomyomas-fibroids-from-uterine-sarcomas?source=machineLearning&search=sarcome+ut\u00e9rin&selectedTitle=2%7E38&sectionRank=2&anchor=H16656415#H [updated 20.02.16, retrieved 1.03.16]."},{"key":"10.1016\/j.jogoh.2018.05.015_bib0275","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1046\/j.1525-1438.2002.01086.x","article-title":"Usefulness of Gd-DTPA contrast-enhanced dynamic MRI and serum determination of LDH and its isozymes in the differential diagnosis of leiomyosarcoma from degenerated leiomyoma of the uterus","volume":"12","author":"Goto","year":"2002","journal-title":"Int J Gynecol Cancer"},{"key":"10.1016\/j.jogoh.2018.05.015_bib0280","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1002\/jmri.20207","article-title":"Smooth muscle tumors of uncertain malignant potential and leiomyosarcomas of the uterus: MR findings","volume":"20","author":"Tanaka","year":"2004","journal-title":"J Magn Reson Imaging"},{"key":"10.1016\/j.jogoh.2018.05.015_bib0285","doi-asserted-by":"crossref","first-page":"2306","DOI":"10.1007\/s00330-013-2819-9","article-title":"How to differentiate benign from malignant myometrial tumours using MR imaging","volume":"23","author":"Thomassin-Naggara","year":"2013","journal-title":"Eur Radiol"},{"key":"10.1016\/j.jogoh.2018.05.015_bib0290","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.2214\/ajr.177.6.1771307","article-title":"MR imaging of uterine sarcomas","volume":"177","author":"Sahdev","year":"2001","journal-title":"AJR Am J Roentgenol"},{"key":"10.1016\/j.jogoh.2018.05.015_bib0295","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1002\/jmri.20207","article-title":"Smooth muscle tumors of uncertain malignant potential and leiomyosarcomas of the uterus: MR findings","volume":"20","author":"Tanaka","year":"2004","journal-title":"J Magn Reson Imaging JMRI"},{"issue":"Spec No. S131-145","key":"10.1016\/j.jogoh.2018.05.015_bib0300","article-title":"Unusual appearances of uterine leiomyomas: MR imaging findings and their histopathologic backgrounds","volume":"19","author":"Ueda","year":"1999","journal-title":"Radiogr Rev Publ Radiol Soc N Am Inc"},{"key":"10.1016\/j.jogoh.2018.05.015_bib0305","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1097\/RCT.0b013e318197ec6f","article-title":"Hyperintense uterine myometrial masses on T2-weighted magnetic resonance imaging: differentiation with diffusion-weighted magnetic resonance imaging","volume":"33","author":"Takeuchi","year":"2009","journal-title":"J Comput Assist Tomogr"},{"key":"10.1016\/j.jogoh.2018.05.015_bib0310","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1007\/s00330-007-0787-7","article-title":"The utility of diffusion-weighted MR imaging for differentiating uterine sarcomas from benign leiomyomas","volume":"18","author":"Tamai","year":"2008","journal-title":"Eur Radiol"},{"key":"10.1016\/j.jogoh.2018.05.015_bib0315","doi-asserted-by":"crossref","first-page":"2756","DOI":"10.1007\/s00330-009-1471-x","article-title":"Combined use of T2-weighted and diffusion-weighted 3-T MR imaging for differentiating uterine sarcomas from benign leiomyomas","volume":"19","author":"Namimoto","year":"2009","journal-title":"Eur Radiol"},{"issue":"2","key":"10.1016\/j.jogoh.2018.05.015_bib0320","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1002\/jmri.24998","article-title":"Comparison of the diagnostic accuracy of contrast-enhanced MRI and diffusion-weighted MRI in the differentiation between uterine leiomyosarcoma\/smooth muscle tumor with uncertain malignant potential and benign leiomyoma","volume":"43","author":"Lin","year":"2016","journal-title":"J Magn Reson Imaging"},{"key":"10.1016\/j.jogoh.2018.05.015_bib0325","series-title":"Canadian Cancer Statistics 2015","author":"Canadian Cancer Society's Advisory Committee on Cancer Statistics","year":"2015"},{"key":"10.1016\/j.jogoh.2018.05.015_bib0330","series-title":"Quantitative Assessment of the Prevalence of Unsuspected Uterine Sarcoma in Women Undergoing Treatment of Uterine Fibroid","author":"FDA","year":"2014"},{"key":"10.1016\/j.jogoh.2018.05.015_bib0335","series-title":"SGO Position Statement: Morcellation. SGO","author":"SGO","year":"2013"},{"key":"10.1016\/j.jogoh.2018.05.015_bib0340","unstructured":"SGO. Statement of the Society of Gynecologic Oncology to the Food and Drug Administration's Obstetrics and Gynecology Medical Devices Advisory Committee Concerning Safety of Laparoscopic Power Morcellation. SGO, 2014, July. Retrieved from: https:\/\/www.sgo.org\/wp-content\/uploads\/2014\/04\/SGO-Testimony-to-FDA-on-Power-Morcellation-FINAL.pdf [13.09.15]."},{"key":"10.1016\/j.jogoh.2018.05.015_bib0345","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1007\/s10397-015-0894-4","article-title":"The prevalence of occult leiomyosarcoma at surgery for presumed uterine fibroids: a meta-analysis","volume":"12","author":"Pritts","year":"2015","journal-title":"Gynecol Surg"},{"issue":"January (1)","key":"10.1016\/j.jogoh.2018.05.015_bib0350","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1097\/AOG.0000000000001187","article-title":"Occult uterine sarcoma and leiomyosarcoma: incidence of and survival associated with morcellation","volume":"127","author":"Raine-Bennett","year":"2016","journal-title":"Obst Gynecol"},{"issue":"12","key":"10.1016\/j.jogoh.2018.05.015_bib0355","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1001\/jama.2014.9005","article-title":"Uterine pathology in women undergoing minimally invasive hysterectomy using morcellation","volume":"312","author":"Wright","year":"2014","journal-title":"JAMA Oncol"},{"issue":"1","key":"10.1016\/j.jogoh.2018.05.015_bib0360","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1001\/jamaoncol.2014.206","article-title":"Use of electric power morcellation and prevalence of underlying cancer in women who undergo myomectomy","volume":"1","author":"Wright","year":"2015","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.jogoh.2018.05.015_bib0365","series-title":"Morcellement par c\u0153lioscopie et ablation chirurgicale de fibromes ut\u00e9rins: Avertissement aux Etats-Unis et rappel des recommandations de l\u2019ANSM \u2013 Point d\u2019Information","author":"ANSM","year":"2015"},{"key":"10.1016\/j.jogoh.2018.05.015_bib0370","series-title":"Ablation chirurgicale de fibromes ut\u00e9rins et morcellement par c\u0153lioscopie: recommandations aux professionnels de sant\u00e9 \u2013 Information de s\u00e9curit\u00e9","author":"ANSM","year":"2015"},{"key":"10.1016\/j.jogoh.2018.05.015_bib0375","article-title":"UPDATED laparoscopic uterine power morcellation in hysterectomy and myomectomy: FDA safety communication","volume":"24","author":"FDA","year":"2014","journal-title":"FDA"},{"issue":"318","key":"10.1016\/j.jogoh.2018.05.015_bib0380","article-title":"Prise en charge des l\u00e9iomyomes ut\u00e9rins","volume":"February","author":"Vilos","year":"2015","journal-title":"SOGC"}],"container-title":["Journal of Gynecology Obstetrics and Human Reproduction"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2468784718301715?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2468784718301715?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,12]],"date-time":"2018-10-12T12:52:43Z","timestamp":1539348763000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2468784718301715"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,10]]},"references-count":38,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2018,10]]}},"alternative-id":["S2468784718301715"],"URL":"https:\/\/doi.org\/10.1016\/j.jogoh.2018.05.015","relation":{},"ISSN":["2468-7847"],"issn-type":[{"value":"2468-7847","type":"print"}],"subject":[],"published":{"date-parts":[[2018,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Can the risks associated with uterine sarcoma morcellation really be prevented? Overview of the role of uterine morcellation in 2018","name":"articletitle","label":"Article Title"},{"value":"Journal of Gynecology Obstetrics and Human Reproduction","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jogoh.2018.05.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}